Z-0736-2023 Class III Ongoing

Recalled by Howmedica Osteonics Corp. — Mahwah, NJ

FDA device recall Z-0736-2023 was initiated by Howmedica Osteonics Corp. on Nov 7, 2022 and is designated Class III. Reason for recall: Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is accurate. The recall status is ongoing. Affected quantity: 2085 units.

Recall Details

Product Type
Devices
Report Date
Dec 28, 2022
Initiation Date
Nov 7, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2085 units

Product Description

Full Dose CE Simplex P Single Bone Cement - Indicated for the fixation of prostheses to living bone in orthopaedic Catalog Number: 6191-0-001

Reason for Recall

Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is accurate.

Distribution Pattern

International distribution in the country of Turkey.

Code Information

UDI# P/N 6191-0-001 (01)07613327128772 (17)261031(10)lot# GTIN: 07613327128772 -Instructions for Use (IFU) received with product: 0700-7-010 (IFU Radiopaque Bone Cement) All lots manufactured under Rev AB, with Exp. Date on/after September 16, 2021.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0736-2023
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.